2023 annual financial data
Immuneering 2023 Financial results
Direct answer
Revenue was 455 USD.
Operating income was -58,412,887 USD and net income was -53,471,622 USD.
Operating cash flow was -48,968,634 USD.
Get free Immuneering email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 455 USD
- Operating income
- -58,412,887 USD
- Net income
- -53,471,622 USD
- Operating cash flow
- -48,968,634 USD
Explore related company data
View all 2023 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all Immuneering financial years